Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia.
about
Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsisA multistep procedure to prepare pre-vascularized cardiac tissue constructs using adult stem sells, dynamic cell cultures, and porous scaffolds.Sodium hydrosulfide prevents myocardial dysfunction through modulation of extracellular matrix accumulation and vascular densityVascular growth factors for coronary angiogenesis.Therapeutic angiogenesis: protein-based therapy for coronary artery disease.Translational physiology: porcine models of human coronary artery disease: implications for preclinical trials of therapeutic angiogenesis.Synthetic chemically modified mRNA (modRNA): toward a new technology platform for cardiovascular biology and medicine.Therapeutic angiogenesis for myocardial ischemia.Therapeutic angiogenesis using vascular endothelial growth factor.Hydrogen sulfide mitigates cardiac remodeling during myocardial infarction via improvement of angiogenesis.Pharmacological revascularisation in coronary and peripheral vascular disease.Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular functionNew strategies for cardiovascular gene therapy: regulatable pre-emptive expression of pro-angiogenic and antioxidant genesAtorvastatin increases myocardial indices of oxidative stress in a porcine model of hypercholesterolemia and chronic ischemia.Exercise-induced expression of VEGF and salvation of myocardium in the early stage of myocardial infarction.Therapeutic angiogenesis for myocardial ischemia revisited: basic biological concepts and focus on latest clinical trials.Vascular endothelial growth factor-delivery systems for cardiac repair: an overview.Cell-based vasculogenic studies in preclinical models of chronic myocardial ischaemia and hibernation.Gene delivery of hypoxia-inducible VEGF targeting collagen effectively improves cardiac function after myocardial infarctionCritical appraisal of the mouse model of myocardial infarction.Evaluation of the porcine ameroid constrictor model of myocardial ischemia for therapeutic angiogenesis studies.Effects of intramyocardial pVEGF165 delivery on regional myocardial blood flow: evidence for a spatial 'delivery-efficacy' mismatch.The efficacy of a 'master switch gene' HIF-1alpha in a porcine model of chronic myocardial ischaemia.Intracoronary delivery of DNAzymes targeting human EGR-1 reduces infarct size following myocardial ischaemia reperfusion.Effect of atorvastatin on the angiogenic responsiveness of coronary endothelial cells in normal and streptozotocin (STZ) induced diabetic rats.Physiological and unappreciated roles of CaMKII in the heart.
P2860
Q30541878-1C381185-23A8-489A-9390-38EDF201A799Q33701439-86441E19-7465-430B-B8CD-0BCFF27DFAFBQ34835381-3AD7CD77-C574-4BD7-8B4C-DE4D7D60B179Q35022906-0A992C98-682B-4A3B-A433-AFA0ADF64141Q35058121-4372762C-5D81-45BD-8F8B-C5D1242FE866Q35101166-862A4984-9F86-476A-9007-4D539E2DDD40Q35319305-2F0E1EC2-48EF-4C96-A0CA-A3283C2E88AAQ35777375-489C1101-D5CA-4CB6-831D-C3624F3B809FQ35814821-F30B9F21-703E-476C-8076-FB718F80C5DDQ35828530-345D5F1F-EBCE-4C46-9368-8D8712DC2D8BQ35906980-820AAA71-0CE2-4AC8-951E-59279FFFDD53Q36095572-5EBA659C-7B07-4879-A6EF-BD034FEF2C97Q36385632-44BEE2F6-C8B5-4AB8-9D59-CEA6894FADA5Q37068764-869E246F-11D4-4390-A7F1-27DEFEBFC037Q37100213-7BB7A4A4-DA5C-4B76-9B8B-BCBDAE520E97Q37961586-A5AA7C59-A243-4902-A324-975A046B88C4Q38022017-1206C507-D2BE-4819-A2AA-AE48D339DED4Q38068940-AD5ADB31-2AB1-4231-A21F-97295D4F1DA4Q42378908-E334A74C-61D6-41FF-98F7-763D3807B02AQ43831854-67D64FB1-A641-4DCD-8E7B-049FCEF60064Q45861500-CBD3EC9E-771F-46C2-AB64-A752BA56593FQ45876218-701AA3DD-D507-472E-BE0A-A2DE507CEB87Q45882738-A7FE4F9C-46EA-4CD6-8A00-D311A557537AQ47325940-38B9CD7C-022A-43C2-A497-B10E2BA7D7F9Q53059087-DE162587-27A6-45F6-85D2-BB35F139DF2CQ55381387-65DC236C-6D2A-4DE5-8874-546E939854E4
P2860
Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Efficacy of intracoronary or i ...... f chronic myocardial ischemia.
@ast
Efficacy of intracoronary or i ...... f chronic myocardial ischemia.
@en
type
label
Efficacy of intracoronary or i ...... f chronic myocardial ischemia.
@ast
Efficacy of intracoronary or i ...... f chronic myocardial ischemia.
@en
prefLabel
Efficacy of intracoronary or i ...... f chronic myocardial ischemia.
@ast
Efficacy of intracoronary or i ...... f chronic myocardial ischemia.
@en
P2093
P1476
Efficacy of intracoronary or i ...... of chronic myocardial ischemia
@en
P2093
F W Sellke
R B Johnson
P304
P356
10.1016/S0735-1097(00)01144-X
P407
P577
2001-02-01T00:00:00Z